{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:08:48Z","timestamp":1761718128147},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.pnpbp.2010.02.011","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T04:35:37Z","timestamp":1266208537000},"page":"522-526","source":"Crossref","is-referenced-by-count":12,"title":["Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"Hideto","family":"Shinno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Innami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hineno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Inami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2010.02.011_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.sleep.2004.01.012","article-title":"Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)","volume":"5","author":"Allen","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"issue":"11","key":"10.1016\/j.pnpbp.2010.02.011_bib3","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.sleep.2008.04.009","article-title":"Periodic leg movements in RLS patients as compared to controls: are there differences beyond the PLM index","volume":"10","author":"Boehm","year":"2009","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.02.011_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0317167100036350","article-title":"The treatment of the restless legs syndrome with clonazepam: a prospective controlled study","volume":"13","author":"Boghen","year":"1986","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/WNL.38.12.1845","article-title":"Treatment of restless legs syndrome and periodic limb movements during sleep with L-dopa: a double-blind, controlled study","volume":"38","author":"Brodeur","year":"1988","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.pnpbp.2010.02.011_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/sleep\/19.10.801","article-title":"Pergolide and carbidopa\/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients","volume":"19","author":"Earley","year":"1996","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.pnpbp.2010.02.011_bib8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.sleep.2008.09.001","article-title":"Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Ferini-Strambi","year":"2008","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.011_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.52.6.1227","article-title":"Switching dopamine agonists in advanced Parkinson's disease","volume":"52","author":"Goetz","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.02.011_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s007020170097","article-title":"Switching from Pergolide to pramipexole in patients with Parkinson's disease","volume":"108","author":"Hanna","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.smrv.2005.12.003","article-title":"Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment","volume":"10","author":"Hornyak","year":"2006","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.011_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"6165","key":"10.1016\/j.pnpbp.2010.02.011_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bmj.1.6165.751","article-title":"Treatment of the restless legs syndrome with clonazepam","volume":"1","author":"Matthews","year":"1979","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.011_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0404.1984.tb07826.x","article-title":"Clonazepam and vibration in restless legs syndrome","volume":"69","author":"Montagna","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.pnpbp.2010.02.011_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: a double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib16","series-title":"Principles and practice of sleep medicine","first-page":"839","article-title":"Restless legs syndrome and periodic limb movements during sleep","author":"Montplaisir","year":"2005"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.02.011_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"The Pramipexole RLS Study Group. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sleep.2006.03.011","article-title":"Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study \u2014 the PRELUDE study","volume":"7","author":"Partinen","year":"2006","journal-title":"Sleep Med"},{"issue":"6296","key":"10.1016\/j.pnpbp.2010.02.011_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.283.6296.885-a","article-title":"Clonazepam: effective treatment for restless legs syndrome in uremia","volume":"283","author":"Read","year":"1981","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.pnpbp.2010.02.011_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.54.5.1064","article-title":"Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly","volume":"54","author":"Rothdach","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.02.011_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(01)00080-3","article-title":"Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam","volume":"11","author":"Saletu","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.pnpbp.2010.02.011_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome","volume":"26","author":"Silber","year":"2003","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.02.011_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.pnpbp.2010.02.011_bib24","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2004.01.031","article-title":"Why do restless legs occur at rest? \u2014 pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2)","volume":"115","author":"Trenkwalder","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.pnpbp.2010.02.011_bib25","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.20983","article-title":"The German RLS-Pramipexole Study Group. Controlled withdrawal of pramipexole after 6months of open-label treatment in patients with restless legs syndrome","volume":"21","author":"Trenkwalder","year":"2006","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.pnpbp.2010.02.011_bib26","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mds.22254","article-title":"Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice","volume":"23","author":"Trenkwalder","year":"2008","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.pnpbp.2010.02.011_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.1990.00530110083021","article-title":"Long-term effect of dopaminergic drugs in restless legs: a 2-year follow-up","volume":"47","author":"von Scheele","year":"1990","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.02.011_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"Winkelman","year":"2004","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.011_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/01.wnl.0000231513.23919.a1","article-title":"Efficacy and safety of pramipexole in restless legs syndrome","volume":"67","author":"Winkelman","year":"2006","journal-title":"Neurol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T01:25:10Z","timestamp":1544664310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0278584610000588"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.02.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}